Breast cancer metastases in the iris: Does treatment modifies natural history of the illness?;Metástasis en iris de un carcinoma de mama: ¿Modifica el tratamiento la historia natural de la enfermedad?

Anales de Medicina Interna

Volumn 25, Issue 4, 2008, Pages 178-180

  Pérez Fidalgo, José Alejandro ^a,b   Vila Arteaga, J ^a   Chirivella Gonzalez I ^a   Martinez Belda R ^a   Bermejo De Lasheras, B ^a   Rosello Keranen S ^a   Fons Moreno, A ^a   Lluch Hernandez A ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Breast cancer; Iris; Ocular metastases; Trastuzumab

Indexed keywords

CARBOPLATIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GEMCITABINE; PACLITAXEL; TRASTUZUMAB;

ADULT; ANAMNESIS; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER CHEMOTHERAPY; CANCER INFILTRATION; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IRIS TUMOR; MAINTENANCE THERAPY; METASTASIS; MULTIPLE CYCLE TREATMENT;

ADULT; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; IRIS NEOPLASMS;

EID: 46849111027     PISSN: 02127199     EISSN: 02127199     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Freedman MI, Folk JC. Metastatic tumors to the eye and orbit. Arch Ophtalmol 1987; 71: 373.
2. Greenlee R, Hill-Harmon M, Murray T. Cancer statistics 2001. CA Cancer J Clin 2001; 51: 15-36.
3. Kreusel KM, Wiegel T, Stange M, Bornfeld N, Foerster MH. Intraocular metastases of metastatic breast carinoma in the woman. Incidence, risk factors and therapy. Ophtalmologe. 2000; 97: 342-6.
4. Shields Cl, Shields JA, Gross NE, Schwartz GP, Lally SE. Survey of 520 eyes with uveal metastases. Ophtalmology 1997; 104: 1265-75.
5. th ed. Philadelphia: Lippincott, Williams and Wilkins; 2004. p.1257-60.
6. Martin M, Zierhut D, Piroth M, Gutwein S, Debus J., Dithmar S. Solitary iris metastasis from breast cancer. Effective local therapy with electron beam irradiation. Ophtalmologe 2006; 103: 48-51.
7. Gutierrez Sanchez E, Alonso Alonso I. Metastasis en el iris: un hallazgo casual. Arch Soc Esp Oftalmol 2000; 75: 689-91.
8. Reddy SC, Madhavan M, Mutum SS. Anterior uveal and episcleral metastases from carcinoma of the breast. Ophtalmologica 2000; 214: 368-72.
9. Hoche A, Blum M, Semeniuk C, Lorenz P, Kosmehl H, Strobel J. Secondary glaucoma caused by iris tumor. Iris metastasis of adenocarcinoma of the breast. Ophtalmologe 1999; 6: 342-3.
10. Escobar R, Ronquillo A, Escobar F, Álvarez-Morujo M. Trabeculectomía por glaucoma secundario a metástasis de carcinoma de mama. Rev Med Univ Navarra 1989; 33: 131-2
11. Bonnet JL, de Marigny G, Marthouret M. Metastasis in the iris of a cancer of the breast. Bull Soc Ophtalmol Fr 1970; 70: 283-5.
12. Shields JA, Shields CL, Kiratli H, de Potter P. Metastatic tumors to the iris in 40 patients. Am J Ophtalmol 1995; 119: 422-30.
13. Demirci H, Shields CL, Chao AN, Shields JA. Uveal metastasis from breast cancer in 264 patients. Am J Ophtalmol 2003; 136: 264-71.
14. Ratanatharathorn V, Powers W, Grimm J. Eye metastasis from carcinoma of the breast: Diagnosis, radiation treatment and results. Cancer Treat Rev 1991; 18: 261.
15. Dawson SJ, Ranieri NF, Snyder RD, McLahlan SA, Burns WI, Newnham GM, Francis PA, Dowling AJ. Trastuzumab and CNS metastases in women with HER-2 positive metastatic breast cancer. J Clin Oncol 2005 ASCO Annual Meeting Proceedings 2005; 23 (16 Supl.): 683.
16. Lai R, Dang CT, Malkin MG, Abrey LE. The risk of central nervous system metastases after trastuzumab therapy in patients with breast carcinoma. Cancer 2004; 104 (4): 810-16.
17. Pestalozzi BC, Zahrieh D, Price KN, Holmberg SB, Lindtner J, Collins J, et al. For the International Breast Cancer Study Group. Identifying breast cancer patients at risk for central nervous system metastases in trials of the International Breast Cancer Study Group. Ann Oncol 2006; 17:935-44.
18. Lower EE, Drosick DR, Blau R, Brennan L, Danneman W, Hawley Dk. Increased rate of brain metastases with trastuzumab therapy not associated with impaired survival. Clin Breast Cancer 2003; 4: 114-9.
19. Pinder MC, Chang H, Broglic KR, Michaud LB, Theriault RL, Sahin A, et al. Trastuzumab treatment and the risk of central nervous system metastases. J Clin Oncol 2007 ASCO Annual Meeting Proceedings Part I 2007; 25 (18 Supl.): 1018.